Article Information
History
- April 15, 2020.
Article Versions
- Version 1 (November 27, 2019 - 08:11).
- Version 2 (March 29, 2020 - 09:00).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Parul Verma1,
- Jayachandran Devaraj2,
- Jodi L. Skiles3,
- Tammy Sajdyk3,
- Richard H. Ho4,
- Raymond Hutchinson5,
- Elizabeth Wells6,
- Lang Li7,
- Jamie Renbarger3,
- Bruce Cooper8 and
- Doraiswami Ramkrishna1,*
- 1Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN, 47907, USA
- 2Active ingredient process development, Corteva Agriscience, Indianapolis, IN, 46268, USA
- 3Indiana University School of Medicine, Indianapolis, IN, 46202, USA
- 4Vanderbilt University, Nashville, TN, 37240, USA
- 5University of Michigan, Ann Arbor, MI, 48109, USA
- 6Children’s Research Institute, Washington, DC, 20010, USA
- 7Ohio State University, Columbus, OH, 43210, USA
- 8Bindley Bioscience Center, Purdue University, West Lafayette, IN, 47907, USA
- ↵*Corresponding author; email: ramkrish{at}ecn.purdue.edu
Posted April 15, 2020.
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
